Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma

By Combaret V.   Gross N.   Lasset C.   Frappaz D.   Beretta-Brognara C.   Philip T.   Beck D.   Favrot M.C.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2101-2105

Elsevier

Access to resources Recommend Favorite

Expression of a 260kDa Neuroblastoma Surface Antigen, the Target of Cytotoxic Natural Human IgM: Correlation to MYCN Amplification and Effects of Retinoic Acid

By David K.   Ehrhardt A.   Ollert M.W.   Erttmann R.   Bredehorst R.   Vogel C.-W.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 1937-1941

Elsevier

Access to resources Recommend Favorite

Analysis of candidate gene co-amplification with MYCN in neuroblastoma

By George R.E.   Kenyon R.   McGuckin A.G.   Kohl N.   Kogner P.   Christiansen H.   Pearson A.D.J.   Lunec J.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2037-2042

Elsevier

Access to resources Recommend Favorite

Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma

By Kaneko Setsuko   Ohira Miki   Nakamura Yohko   Isogai Eriko   Nakagawara Akira   Kaneko Michio  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 3, 2007-03 ,pp. : 185-192

Springer Publishing Company

Access to resources Recommend Favorite

Correlation of E-cadherin and CD44v6 expression with clinical pathology in esophageal carcinoma

By              

Molecular Medicine Reports, Vol. 5, Iss. 3, 2012-01 ,pp. : 817-821

Spandidos Publications

Access to resources Recommend Favorite